RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

FINANCIAL CONSULATE, INC's Holding History (CIK: 0001624510)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 418 Value ($000) $2 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 418 Value ($000) $2 Avg Close $5.25 Range $4.45 - $7.15